Lipirose-Gold 10 Capsule is a combination pharmaceutical formulation containing Aspirin (75 mg), Rosuvastatin (10 mg), and Clopidogrel (75 mg), designed to provide comprehensive cardiovascular protection. Aspirin, a well-known antiplatelet agent, irreversibly inhibits cyclooxygenase-1 (COX-1), thereby reducing thromboxane A2 production and preventing platelet aggregation. Rosuvastatin, a potent HMG-CoA reductase inhibitor, effectively lowers low-density lipoprotein cholesterol (LDL-C) and exerts pleiotropic effects including improvement of endothelial function and stabilization of atherosclerotic plaques. Clopidogrel, another antiplatelet agent, selectively inhibits the ADP receptor P2Y12 on platelet surfaces, further reducing platelet activation and aggregation. The combination of these agents is indicated for the prevention of atherothrombotic events in patients with established cardiovascular disease or those at high risk, such as individuals with recent myocardial infarction, ischemic stroke, or peripheral arterial disease. Lipirose-Gold 10 Capsule should be administered under medical supervision, considering potential contraindications such as active bleeding, hypersensitivity, or hepatic impairment. Caution is advised due to increased bleeding risk associated with dual antiplatelet therapy. Regular monitoring of lipid profiles, liver function tests, and hematologic parameters is recommended to ensure therapeutic efficacy and safety.